Cargando…
PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT?
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431633/ http://dx.doi.org/10.1097/01.HS9.0000851140.58553.2a |
| _version_ | 1784780110082080768 |
|---|---|
| author | Freitas, J. Pereira, D. Moreira, C. Chacim, S. Domingues, N. Espírito Santo, A. Martins, Â. Oliveira, I. Viterbo, L. Moreira, I. Mariz, J. |
| author_facet | Freitas, J. Pereira, D. Moreira, C. Chacim, S. Domingues, N. Espírito Santo, A. Martins, Â. Oliveira, I. Viterbo, L. Moreira, I. Mariz, J. |
| author_sort | Freitas, J. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431633 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94316332022-08-31 PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? Freitas, J. Pereira, D. Moreira, C. Chacim, S. Domingues, N. Espírito Santo, A. Martins, Â. Oliveira, I. Viterbo, L. Moreira, I. Mariz, J. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431633/ http://dx.doi.org/10.1097/01.HS9.0000851140.58553.2a Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Freitas, J. Pereira, D. Moreira, C. Chacim, S. Domingues, N. Espírito Santo, A. Martins, Â. Oliveira, I. Viterbo, L. Moreira, I. Mariz, J. PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? |
| title | PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? |
| title_full | PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? |
| title_fullStr | PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? |
| title_full_unstemmed | PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? |
| title_short | PB2077: POD12 AND POD24 – A NEW SURROGATE MARKER IN MANTLE CELL LYMPHOMA TREATMENT? |
| title_sort | pb2077: pod12 and pod24 – a new surrogate marker in mantle cell lymphoma treatment? |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431633/ http://dx.doi.org/10.1097/01.HS9.0000851140.58553.2a |
| work_keys_str_mv | AT freitasj pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT pereirad pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT moreirac pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT chacims pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT dominguesn pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT espiritosantoa pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT martinsa pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT oliveirai pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT viterbol pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT moreirai pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment AT marizj pb2077pod12andpod24anewsurrogatemarkerinmantlecelllymphomatreatment |